CAS: 69123-94-0; 1-((2R,3S,4R,5R)-3-Fluoro-4-Hydroxy-5-(Hydroxymethyl)Tetrahydrofuran-2-yl)Pyrimidine-2,4(1H,3H)-Dione

该化合物是一个合成核素模拟,与自然产生的核素有结构相似.该化合物具有一个含有青米丁和二酮功能的双环结构.在阿拉伯丙酰胺混合物上存在一个脱氧和氟组,这增加了其生物活动的潜力,特别是在抗病毒和抗癌应用方面.氟替代可影响该化合物的代谢稳定性和与核酸目标的相互作用.其独特的结构使其能够有可能干扰核酸合成,使其成为进一步研究医药化学的候选条件.此外,该化合物的溶性,稳定性和再活性可因环境条件而变化,而这些条件是其药用评估的关键因素.

结构式图片

相似化合物

784-71-4 114248-23-6 163252-36-6

上下游产品

CAS号66-22-8 尿嘧啶 | CAS号122757-52-2 1-[(2R,5S)-3-Fl...

合成工艺路线路线简述

    非阿尿苷置于palladium On Activated Charcoal 氢气,三乙胺体系中,用 甲醇,水 作为反应溶剂,化学反应 18.0H,以90.3%的收率获得产物1-(2-脱氧-2-氟-Beta-D-阿拉伯呋喃基)尿嘧啶
    参考文献:几种含2'-氟嘧啶核苷的合成及其抗hiv活性.
    标题:几种含2'-氟嘧啶核苷的合成及其抗hiv活性.
    摘要:报道了几种2'-氟阿拉伯糖-2',3'-二脱氧-和2'-氟-2',3'-不饱和的2',3'-二脱氧嘧啶核苷类似物.饱和的类似物1-(2,3-二脱氧-2-氟-β-D-苏-五氟呋喃糖基)胸腺嘧啶(2'-Threo-Fddt,33),1-(2,3-二脱氧-2-氟-β-胸腺嘧啶通过相应的2'-脱氧-2'-氟阿拉伯糖基核苷类似物,通过3'-Oh的自由基脱氧,可以轻松制备-D-苏-五氟呋喃糖基)尿嘧啶(2'-苏-Fddu,22).不饱和化合物1-(2,3-二脱氧-2-氟-β-D-甘油-戊-2-烯呋喃糖基)胸腺嘧啶(2'-Fd4T,40)和1-[5-O-(单甲氧基三苯甲基)通过o-2,3'-脱水-2'-氟代-的消除反应,合成了-2-氟-2,3-二脱氧-β-D-甘油-Pen T-2--呋喃糖基]尿嘧啶(39). Lyxo衍生物在基本条件下.胞苷类似物28和41是通过氨基化相应的尿苷衍生物制备的;使化合物28和41脱保护,得到1-(2
    DOI:10.1021/jm00170A017

    海关参考信息

    专利信息


    专利号:US-8912319-B2
    优先权日:2010-07-15
    标 题 :Synthesis of 2′-deoxy-2′-[18F]fluoro-5-methyl-1-B-D-arabinofuranosyluracil (18F-FMAU)
    发明人:LI ZIBO; CAI HANCHENG; CONTI PETER S
    权利人:LI ZIBO; CAI HANCHENG; CONTI PETER S; UNIV SOUTHERN CALIFORNIA
    摘要:The present invention relates to methods of synthesizing 18 F-FMAU. In particular, 18 F-FMAU is synthesized using one-pot reaction conditions in the presence of Friedel-Crafts catalysts. The one-pot reaction conditions are incorporated into a fully automated cGMP-compliant radiosynthesis module, which results in a reduction in synthesis time and simplifies reaction conditions. The one-pot reaction conditions are also suitable for the production of 5-substituted thymidine or cytidine analogs. The products from the one-pot reaction (e.g. the labeled thymidine or cytidine analogs) can be used as probes for imaging tumor proliferative activity. More specifically, these [ 18 F]-labeled thymidine or cytidine analogs can be used as a PET tracer for certain medical conditions, including, but not limited to, cancer disease, autoimmunity inflammation, and bone marrow transplant.

    专利号:US-2023416293-A1
    优先权日:2020-11-23
    标 题:Synthesis of [18f]-labeled thymidine analogues
    发明人:CHEN KAI; CONTI PETER S
    权利人:UNIV SOUTHERN CALIFORNIA
    摘要:Thymidine analogues, 5-substituted 2′-deoxy-2′-[18F]fluoro-arabinofuranosyluracil derivatives, are promising positron emission tomography (PET) tracers being evaluated for noninvasively imaging cancer cell proliferation and/or reporter gene expression. We report the radiosynthesis of 2′-deoxy-2′-[18F]fluoro-5-methyl-1-β-d-arabinofuranosyluracil ([18F]FMAU) and other 2′-deoxy-2′-[18F]fluoro-5-substituted-1-β-d-arabinofuranosyluracil analogues using 1,4-dioxane to replace the currently used 1,2-dichloroethane. Compared to 1,2-dichloroethane, 1,4-dioxane is analyzed as a better solvent in terms of radiosynthetic yield and toxicity concern. The use of a less toxic solvent allows for the translation of the improved approach to clinical production. The new radiolabeling method can be applied to an extensive range of uses for 18F-labeling of other nucleoside analogues.

    专利号:US-9422321-B2
    优先权日:2010-09-07
    标题 :Pyrimidine nucleoside derivatives, synthesis methods and uses thereof for preparing anti-tumor and anti-virus medicaments
    发明人:CHANG JUNBIAO; AN HAOYUN; YU XUEJUN; GUO XIAOHE
    权利人:CHANG JUNBIAO; AN HAOYUN; YU XUEJUN; GUO XIAOHE; HIGH & NEW TECH RES CENTER HENAN ACAD OF SCIENCES; ZHENGZHOU GRANLEN PHARMATECH LTD; UNIV ZHENGZHOU
    摘要:The present invention relates to the field of pharmacochemistry. Disclosed are fluorinated and azido-substituted pyrimidine nucleoside derivatives, particularly compounds of the formula shown below: n nAlso disclosed are methods of preparation and uses for these compounds. The compounds can be used for preparing medicaments for treating diseases such as tumors and viral infections, and can be used separately or in combination with other medicaments. The compounds also have effective activity against diseases such as tumors and viral infections, while having few side effects, and thus have potential application value.

    专利号:WO-2025215034-A1
    优先权日:2024-04-10
    标 题 :Synthesis and application of magnetic particle conjugates for the extracorporeal removal of antibodies targeting viral vectors to facilitate gene therapy
    发明人:LANGENEGGER LUKAS; MORA CARLOS; RIJSBERGEN LAURINE; BENZ SEBASTIAN; KELLER SARAH
    权利人:HEMOTUNE AG
    摘要:The present invention provides novel conjugates comprising a magnetic particle and a multitude of viral structures covalently bound to said particle. These conjugates are suited for efficient extracorporeal removal of antibodies from blood. In particular, the conjugates are suited as adjuvant treatment in gene therapy.

    专利号:US-2009298708-A1
    优先权日:2006-08-23
    标题 :2'-deoxy-2'-fluoro-beta-d-arabinonucleoside 5'-triphosphates and their use in enzymatic nucleic acid synthesis
    发明人:MASAD DAMHA J; GENG PENG CHANG
    权利人:MASAD DAMHA J; GENG PENG CHANG
    摘要:The invention relates to arabinose modified nucleoside 5′ triphosphates and to the biosynthesis and amplification of oligonucleotides containing and/or from templates containing arabinose modified nucleosides. The invention further relates to methods of generating modified oligonucleotide libraries for use in selection strategies, such as SELEX. The arabinose modified oligonucleotides of the invention are useful for modulating target nucleic acid expression, such as RNA.

    专利号:CA-2804823-A1
    优先权日:2010-07-15
    标题:Synthesis of 2'-deoxy-2'-[18f]fluoro-5-methyl-1-b-d-arabinofuranosyluracil (18f-fmau)
    南京爱莉生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.ailychem.com
    企业联系电话:025-83208295👤
    📞南京爱莉生物科技有限公司 ⚠️参考联系方式
    联系人:陈先生
    电话:025-83208295
    手机:18913388297
    传真:025-83208202
    邮箱:ben@ailychem.com
    通信地址: 云南北路83号天鹤文云商务大厦1008室
    邮编: 210009
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:云南北路83号天鹤文云商务大厦1008室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    郑州格然林科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.granlen.com
    电话: 0371-85513397👤
    📞郑州格然林科技有限公司 ⚠️参考联系方式

    销售电话:0371-85513397
    邮箱:info@granlen.com;liyuanzhe@granlen.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Robak T, Robak P. Purine Nucleoside Analogs In The Treatment Of Rarer Chronic Lymphoid Leukemias. Curr Pharm Des. 2012;18(23):3373-88.

    合成参考文献


    参考文献:10.1128/aac.29.1.77
    摘要:Schinazi RF, Fox JJ, Watanabe KA, Nahmias AJ. Activities of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with herpes simplex virus type 2. Antimicrob Agents Chemother. 1986 Jan;29(1):77–84.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知